← Back to Clinical Trials
Recruiting NCT07782099

NCT07782099 Accessory Inspiratory Muscles in Chronic Neck Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07782099
Status Recruiting
Phase
Sponsor Kocaeli Sağlık ve Teknoloji Üniversitesi
Condition Chronic Neck Pain
Study Type OBSERVATIONAL
Enrollment 10 participants
Start Date 2026-06-10
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Diaphragm UltrasonographyAnterior Scalene Muscle UltrasonographyUpper Trapezius Muscle Ultrasonography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10 participants in total. It began in 2026-06-10 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This cross-sectional case-control study aims to investigate the ultrasonographic structural and functional characteristics of accessory inspiratory muscles in individuals with chronic non-specific neck pain and compare them with healthy controls. In addition, the relationships between accessory inspiratory muscle characteristics, diaphragm function, respiratory muscle strength, and pulmonary function parameters will be examined. The findings may improve understanding of the respiratory involvement associated with chronic neck pain and contribute to more comprehensive assessment strategies.

Eligibility Criteria

Inclusion Criteria Chronic Non-Specific Neck Pain Group: * Age between 18 and 65 years * Presence of chronic non-specific neck pain for at least 3 months * Non-traumatic origin of neck pain * Pain intensity ≥ 3 on the Numeric Pain Rating Scale (NPRS) or Visual Analog Scale (VAS) * Neck Disability Index (NDI) score ≥ 15 * Willingness to participate and provide informed consent Healthy Control Group: * Age between 18 and 65 years * No neck pain during the previous 3 months * Not receiving any treatment related to the cervical region * Willingness to participate and provide informed consent Exclusion Criteria (Both Groups): * History of whiplash injury or cervical trauma * Previous cervical spine surgery * Cervical radiculopathy or neurological deficits * Chronic respiratory diseases (e.g., COPD, asthma) * Active respiratory tract infection * Thoracic or abdominal surgery within the previous 6 months * Rheumatologic, neuromuscular, or systemic inflammatory disorders * Pregnancy * Physiotherapy treatment for neck pain within the previous 3 months * Regular respiratory muscle training or breathing exercises within the previous 3 months * Inability to comply with study procedures or assessments

Contact & Investigator

Central Contact

Hatice Sena Çınarlı, assisstant professor

✉ haticesena.cinarli@kocaelisaglik.edu.tr

📞 05436093619

Frequently Asked Questions

Who can join the NCT07782099 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07782099 currently recruiting?

Yes, NCT07782099 is actively recruiting participants. Contact the research team at haticesena.cinarli@kocaelisaglik.edu.tr for enrollment information.

Where is the NCT07782099 trial being conducted?

This trial is being conducted at Kocaeli, Turkey (Türkiye).

Who is sponsoring the NCT07782099 clinical trial?

NCT07782099 is sponsored by Kocaeli Sağlık ve Teknoloji Üniversitesi. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology